Goldman Sachs
CHTP

Goldman Sachs’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Goldman Sachs’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-53,345
Closed -$294K – 7305
2014
Q1 		$294K Sell
53,345
-102,791
-66% -$516K ﹤0.01% 5757
2013
Q4 		$692K Buy
156,136
+73,801
+90% +$249K ﹤0.01% 5051
2013
Q3 		$246K Sell
82,335
-120,220
-59% -$345K ﹤0.01% 5716
2013
Q2 		$466K Buy
+202,555
New +$410K ﹤0.01% 4997

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Goldman Sachs's CHTP Position: Q2 2014 in Review

Goldman Sachs sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 53,345 shares — an estimated $294K sold.

Goldman Sachs first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $692K in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Goldman Sachs reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Goldman Sachs sold 53,345 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $294K.
  • Goldman Sachs first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Goldman Sachs's CHELSEA THERAPEUTICS INT'L LTD position peaked at $692K in Q4 2013.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Goldman Sachs's 13F filing for Q2 2014, filed 14 Aug 2014.